Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.

    Abdalla Awidi, Farah Qasem, A'sem Abu-Qamar, Batool Aqel, Rand Aladayleh, Ilham Alteerah, Ahmad Magableh, , Hisham Bawa”neh, Feras Al-fararjeh
    e2022031
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.031
    1352
    PDF: 772
    HTML: 413
  • ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY

    Eldad J Dann
    e2014063
    2014-09-05
    https://doi.org/10.4084/mjhid.2014.063
    2176
    PDF: 1343
    HTML: 3509
  • THE TREATMENT OF ADVANCED-STAGE MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A HEMATOLOGIST'S POINT OF VIEW.

    Antonio Giordano, Livio Pagano
    e2022029
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.029
    2328
    PDF: 1059
    HTML: 390
  • MONITORING OF PARTICLE ENVIRONMENTAL POLLUTION AND FUNGAL ISOLATIONS DURING HOSPITAL BUILDING-WORK ACTIVITIES IN A HEMATOLOGY WARD.

    Fabio Pattavina, Daniele Ignazio La Milia, Sara Vincenti, Barbara Fiori, Riccardo Torelli, Malgorzata Wachocka, Umberto Moscato, Simona Sica, Walter Ricciardi, Patrizia Laurenti
    e2019062
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.062
    1453
    PDF: 814
    HTML: 276
  • Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy

    Gianluca Cavallaro
    e2024049
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.049
    2266
    HTML: 149
    PDF: 1170
  • CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

    Michele Bibas, Jorge J Castillo
    e2014064
    2014-10-22
    https://doi.org/10.4084/mjhid.2014.064
    2678
    PDF: 1657
    HTML: 2441
    Table1: 206
  • PATHOBIOLOGY AND TREATMENT OF HEPATITIS VIRUS-RELATED THROMBOCYTOPENIA

    Roberto Stasi, Lian Wea Chia, Pallavi Kalkur, Robert Lown, Muriel S. Shannon
    e2009023
    https://doi.org/10.4084/mjhid.2009.023
    897
    PDF: 603
    HTML: 1464
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1584
    PDF: 1203
    HTML: 535
  • Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance

    Holly Lee, Peter Duggan, Ernesta Paola Neri, Jason Tay, Victor Jimenez Zepeda
    e2019007
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.007
    2368
    PDF: 1195
    HTML: 393
  • Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines

    Alex Shimanovsky, Devbala Patel, Jeffrey Wasser
    e2016010
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.010
    4406
    PDF: 1233
    HTML: 2374
    Figure 1: 183
  • “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

    Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin
    e2016047
    2016-10-15
    https://doi.org/10.4084/mjhid.2016.047
    4050
    PDF: 1078
    HTML: 3892
    Untitled: 185
    Cneo. Fig.1: 122
    Untitled: 114
    Untitled: 142
    Untitled: 147
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5338
    PDF: 1980
    HTML: 1788
  • FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT

    Alessia Castellino, Umberto Vitolo
    e2017009
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.009
    4526
    PDF: 1666
    HTML: 4227
    Tables and Images: 253
  • THE BROAD-RANGING PANORAMA OF SYSTEMIC AUTOINFLAMMATORY DISORDERS WITH SPECIFIC FOCUS ON ACUTE PAINFUL SYMPTOMS AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN

    Donato Rigante
    e2018067
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.067
    2163
    PDF: 1332
    HTML: 973
  • Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia

    Zhan Su, Feng Wang
    e2025063
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.063
    913
    PDF: 527
    HTML: 233
    Suppl. Files: 337
  • COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

    Afadil Adam
    e2020070
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.070
    1777
    PDF: 1157
    HTML: 322
  • Spontaneous pneumothorax in an allogeneic cell transplant recipient with invasive pulmonary aspergillosis and antecedent RSV pneumonitis

    Liang Piu Koh, Michelle L Poon, John K Tam, Lynette Teo, Li Yang Hsu
    e2011014
    2011-03-29
    https://doi.org/10.4084/mjhid.2011.014
    1056
    PDF: 872
    HTML: 15544
  • T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections

    Muhamad R. Abdel Hameed, Sherein G. Elgendy, Mohamed A El-Mokhtar, Douaa Sayed, Samar M. Mansour, Abeer M. Darwish
    e2022022
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.022
    1848
    PDF: 735
    HTML: 425
  • IMPACT OF RED CELL EXCHANGE TRANSFUSION ON INFLAMMATORY MARKERS IN SICKLE CELL DISEASE

    Adriana Costa, Inês Mendes, Joana Lage, Marta Moniz, Catarina Amorim, Pedro Nunes, Helena Almeida, Carlos Escobar, Ana Ventura, Teresa Ferreira
    e2025011
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.011
    2046
    PDF: 1356
    HTML: 240
  • COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

    Federico Mercolini, Simone Cesaro
    e2022009
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.009
    2598
    PDF: 966
    HTML: 547
  • CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.

    Luciana Teofili, Immacolata Izzi, Eugenia Rosa Nuzzolo, Giancarlo Scoppettuolo, Katleen de Gaetano Donati, Lorenza Torti, Marianna Rossi
    e2012062
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.062
    1703
    PDF: 749
    HTML: 1668
  • GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

    Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau
    e2011019
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.019
    2648
    PDF: 828
    HTML: 5361
  • Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience

    Edoardo Olivari
    e2025040
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.040
    1092
    PDF: 796
    HTML: 196
  • COMPARISON OF THE POWER OF PROCALCITONIN AND C-REACTIVE PROTEIN TO DISCRIMINATE BETWEEN DIFFERENT AETIOLOGIES OF FEVER IN PROLONGED PROFOUND NEUTROPENIA: A SINGLE-CENTRE PROSPECTIVE OBSERVATIONAL STUDY.

    Anke Verlinden, Veronique De Vroey, Herman Goossens, Ella Roelant, Ann Van de Velde, Zwi Berneman, Wilfried Schroyens, Alain Gadisseur
    e2019023
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.023
    6824
    PDF: 1115
    HTML: 500
  • THE CHALLENGE OF AML IN OLDER PATIENTS

    Alan K Burnett
    e2013038
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.038
    2314
    PDF: 1007
    HTML: 2221
  • EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA

    Ulrike Binder, Cornelia Lass-Flörl
    e2011016
    2011-03-30
    https://doi.org/10.4084/mjhid.2011.016
    2313
    PDF: 1006
    HTML: 4972
  • Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis

    Uday P Kulkarni, Anna Valson, Anila Korula, Vikram Mathews
    e2015043
    2015-07-01
    https://doi.org/10.4084/mjhid.2015.043
    1656
    PDF: 801
    HTML: 1328
  • AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.

    Pasquale Niscola
    e2014020
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.020
    2264
    PDF: 921
    HTML: 2788
  • Pneumatosis cystoides intestinalis with fatal air embolism after minor blunt abdominal trauma in a 6-year-old girl undergoing hematopoietic stem cell trasplant: case report and review of literature

    Matteo Chinello, Olivia Chapin Arnone, Silvia Artusa, Giorgia Mazzuca, Elisa Bonetti, Virginia Vitale, Ada Zaccaron, Dario Raniero, Simone Cesaro
    e2024028
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.028
    677
    PDF: 1171
    HTML: 110
  • Ixazomib-associated skin exfoliation

    Yali Zhang, Long Zhao, Yuancheng Guo, bei liu
    e2022045
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.045
    896
    PDF: 572
    HTML: 246
  • CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

    Ugo Testa, Elvira Pelosi, Dr. Germana Castelli
    e2024077
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.077
    1803
    PDF: 883
    HTML: 1045
  • Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments

    NICOLA SGHERZA, Anna Mestice, Angela Maria Vittoria Larocca, Pellegrino Musto
    e2024022
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.022
    801
    PDF: 1177
    HTML: 94
  • Increased mortality in male recipients of red cells from ever pregnant female donors : mHAGs on red cells to blame ?

    Kanjaksha Ghosh
    e2018009
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.009
    2860
    PDF: 671
    HTML: 412
  • Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

    Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti
    e2022043
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.043
    1549
    PDF: 612
    HTML: 254
  • HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré
    e2014050
    2014-07-01
    https://doi.org/10.4084/mjhid.2014.050
    2973
    PDF: 1399
    HTML: 3719
    Untitled: 208
    Untitled: 221
    Untitled: 195
  • ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN

    Marco Gabbianelli, Ugo Testa
    e2009009
    2009-11-12
    1180
    PDF: 488
    HTML: 4613
  • CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

    Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi
    e2010017
    2010-06-18
    https://doi.org/10.4084/mjhid.2010.017
    1746
    PDF: 757
    HTML: 2349
  • The Efficacy and Safety of Sofosbuvir Containing Regimen in the Treatment of Hcv Infection in Patients with Haemoglobinopathy

    Nawfal R Hussein
    e2017005
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.005
    1639
    PDF: 837
    HTML: 665
  • NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms

    Gianfranco Catalano, Pasquale Niscola, Cristina Banella, Daniela Diverio, Malgorzata Monika Trawinska , Stefano Fratoni, Rita Iazzoni, Paolo de Fabritiis, Elisabetta abruzzese, Nelida Ines Noguera
    e2020083
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.083
    1780
    PDF: 1224
    HTML: 318
  • A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

    Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci
    e2023012
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.012
    1046
    PDF: 979
    HTML: 419
  • EBV AND HIV-RELATED LYMPHOMA

    Michele Bibas, Andrea Antinori
    e2009032
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.032
    1631
    PDF: 650
    HTML: 7189
  • Nodular lymphocyte-predominant Hodgkin lymphoma in a patient with Familial Mediterranean Fever

    Marina Belia, Asimina Papanikolaou, Panagiotis Skendros, Theodoros Vassilakopoulos
    e2022059
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.059
    1015
    PDF: 535
    HTML: 304
  • HYDROXYCARBAMINE: FROM AN OLD DRUG USED IN MALIGNANT HEMOPATHIES TO A CURRENT STANDARD IN SICKLE CELL DISEASE

    Giovanna Cannas, Solene Poutrel, Xavier Thomas
    e2017015
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.015
    4016
    PDF: 1203
    HTML: 1828
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN

    Ramzi Jeddi, Hèla Ghédira, Ramzi Ben Amor, Yosr Ben Abdennebi, Kacem Karima, Zarrouk Mohamed, Hend Ben Neji, Lamia Aissaoui, Raihane Ben Lakhal, Naouel Ben Salah, Samia Menif, Zaher Belhadjali, Hela Ben Abid, Emna Gouider, Raouf Hafsia, Ali Saad, Pierre Fenaux, Balkis Meddeb
    e2011033
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.033
    4034
    PDF: 769
    HTML: 1885
  • PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.

    Ariel Koren, Lora Profeta, Luci Zalman, Haya Palmor, Carina Levin, Ronit Bril Zamir, Stavit Shalev, Orna Blondheim
    e2014012
    2014-02-17
    https://doi.org/10.4084/mjhid.2014.012
    3060
    PDF: 1285
    HTML: 11855
  • FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS.

    Luca Guarnera, Gentiana Elena Trotta, Valentina Boldrini, Lucia Cardillo, Ilaria Cerroni, Valeria Mezzanotte, Gianmario Pasqualone, Arianna Savi, Beatrice Borsellino, Elisa Buzzatti, Raffaele Palmieri, Giovangiacinto Paterno, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe
    e2023013
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.013
    2338
    PDF: 1190
    HTML: 521
  • Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA

    Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni
    e2025045
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.045
    1741
    PDF: 1295
    HTML: 512
  • OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Paola Angelini, Laura Rodriguez, Mohammed Zolaly, Ahmed Naqvi, Sheila Weitzman, oussama Abla, Angela Punnett
    e2018020
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.020
    2944
    PDF: 858
    HTML: 426
  • Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases

    Mariam Markouli, Panagiotis Diamantopoulos, Asimenia Halioti, Stavroula Lontou, Marina Mantzourani
    e2026006
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.006
    929
    PDF: 674
    Suppl. Files: 140
    HTML: 129
  • GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS

    Ravindra Kumar, Kritanjali Singh, Inusha Panigrahi, Sarita Agarwal
    e2013003
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.003
    1816
    PDF: 1317
    HTML: 11568
    Figure1: 187
    Figure 2: 191
251 - 300 of 316 items << < 1 2 3 4 5 6 7 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.